CARTER PIEPER: Open Payments
NPI 1124510193 · CHATTANOOGA, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$514 in 25 payments from 10 companies in 2025. Trend: 2023 $1,474 · 2024 $1,364 · 2025 $514
Food & beverage: $514
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 7 | $155 |
| Abbott Laboratories | 4 | $94 |
| Lilly USA, LLC | 4 | $68 |
| Boston Scientific Corporation | 2 | $47 |
| PFIZER INC. | 2 | $37 |
| AstraZeneca Pharmaceuticals LP | 2 | $36 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $21 |
| Astellas Pharma US Inc | 1 | $21 |
| Sumitomo Pharma America, Inc. | 1 | $19 |
| Inspire Medical Systems, Inc. | 1 | $16 |
Products named: FREESTYLE LIBRE 3, Ozempic, Rybelsus, MOUNJARO, ELIQUIS, FARXIGA, General - Erectile Dysfunction, Wegovy.
Industry payments across TN — which companies pay providers there.
